The PITX2 'homeobox' and FOXC1 and FOXC2 'forkhead box' transcription factors are critical for eye development and cause human ocular diseases when mutated. We have identified biochemical and genetic links between these transcription factors and a transcriptional regulator protein PRKC apoptosis Wilms' tumor 1 regulator (PAWR) that we propose to functionally connect all these proteins in a common pathway critically involved in eye development. We discovered all binary physical interactions between FOXC1, PITX2, FOXC2 and PAWR. Importantly, PAWR modulates the abilities of PITX2, FOXC1 and FOXC2 to activate their genetic targets. Together with either FOXC1 or FOXC2, PAWR increases PITX2 activity. PAWR reduces PITX2 activity in the absence of FOXC1 or FOXC2. At the same time, PAWR also exerts different regulatory effects on different FOXC target sites. Furthermore, morpholino knockdown of pitx2, foxc1 and pawr in zebrafish indicate that PAWR, FOXC1 and PITX2 genetically interact, and are in the same developmental pathway. These data for the first time tie PITX2, FOXC1, FOXC2 and PAWR into a common regulatory pathway. We have therefore identified a functional link between three transcription factors, modulated by PAWR, which we propose underlies the similar ocular phenotypes and glaucoma pathology caused by mutations of these genes.
INTRODUCTION
The development of the vertebrate eye comprises a series of inductive events. A number of genes that include transcription factors, growth factors, nuclear proteins and enzymes are involved in multiple cascades of events in ocular development and other developmental processes. These developmental regulatory networks are therefore not only important in the development of the eye but also in the development of the whole embryo as well. Any abnormalities such as mutations and deleterious changes in these genes could hamper these regulatory networks and therefore result in general developmental defects associated with eye-related problems.
The Pituitary homeobox 2 (PITX2) and Forkhead box C (FOXC1) proteins are examples of such transcription factors. PITX2 is a member of the paired-bicoid family of homeodomain (HD) transcription factors. Pituitary homeobox proteins are actively involved in a wide range of developmental processes, including formation of the pituitary gland, hind limb and anterior segment of the eye and brain morphogenesis (1) (2) (3) .
FOXC1 is a member of the FOX class of transcription factors, characterized by a conserved 110 amino acid DNA-binding domain, known as forkhead domain (FHD) . FOX proteins are key regulators of diverse cellular functions, including the development of many organ systems, energy homeostasis and oncogenesis (4 -6) . Mutations in both FOXC1 and PITX2 are directly associated with Axenfeld-Rieger syndrome (ARS). ARS comprises a group of autosomal dominant clinical disorders affecting anterior eye structures derived from constituents of the embryonic neural crest (7) . Classic ocular features of ARS include iridocorneal synechiae, iris hypoplasia (IH), corectopia, polycoria and/or prominent Schwalbe's line (8, 9) . Malformation of the anterior angle between iris and cornea can lead to elevated intra-ocular pressure and subsequent glaucomatous condition. Approximately 50% of ARS patients develop glaucoma with a variable, but often early, age of onset (10) . Systemic manifestations of ARS often include mild craniofacial dysmorphism, dental defects and/or excessive pre-umbilical skin (11) . Numerous pathologic PITX2 mutations including missense variations, splice-site alterations and * To whom correspondence should be addressed at: Department of Medical Genetics, University of Alberta, Medical Sciences Building, Edmonton, AB, Canada T6G 2H7. Tel: +1 7804923028; Fax: +1 7804921998; Email: moulinat@ulaberta.ca or moulinath@gmail.com insertions/deletions have been described, producing a continuum of clinical phenotypes, including ARS, iridogoniodysgenesis and IH (12) (13) (14) , as well as rarer cases of a Peter's-like anomaly (15) . The mutation spectrum for FOXC1 largely comprises frameshift and nonsense mutations occurring upstream of the FHD that encode truncated proteins, as well as missense mutations occurring within the FHD itself (16) . Moreover, interstitial duplications of the FOXC1 gene can also lead to anterior segment dysgenesis and glaucoma, indicating the necessity of a stringent control of FOXC1 levels and activities (17) (18) (19) . The analyses of AR-causing FOXC1 missense mutations reveal defects in protein stability, nuclear localization, DNA-binding specificity and transcriptional activation. Ultimately, these mutations disrupt the proper activation of FOXC1-target genes (20) (21) (22) .
FOXC2 is a closely related forkhead box transcription factor that also plays an important role in ocular and other developmental processes. Mutations in FOXC2 are directly linked to Lymphedema with Distichiasis syndrome (LD). LD is a rare developmental disorder that affects the formation of the lymphatic vasculature system (23) . Affected individuals typically exhibit distichiasis, an accessory row of eyelashes. These superfluous lashes, arising from the meibomian glands, may abrade the cornea, resulting in corneal epithelial defects and opacification. Additional features of FOXC2 mutations may include cardiac defects, cleft palate and extradural cysts (24) . FOXC1 and FOXC2 are the two members of the FOXC subfamily. The chromosomal localization and genomic organization of these two genes suggest that they may have derived from a common ancestral gene through inter-and intra-chromosomal duplications (4, 6) . Therefore, these two proteins share a strong amino acid sequence homology. FOXC1 and FOXC2 share 98% sequence identity at their FHD with only two amino acid differences (25) . During mouse embryonic development, Foxc1 and Foxc2 have largely overlapping expression patterns (26, 27) .
Previous work from our laboratory indicates that PITX2 and FOXC1 physically interact with each other, not only establishing both proteins into a common pathway but also indicating that PITX2 is a negative regulator of FOXC1 (28) . Recently, we discovered the PRKC Apoptosis Wilms' tumor 1 (WT1) Regulator (PAWR) protein as a novel PITX2 interacting protein that inhibits PITX2 activity in human trabecular meshwork (HTM) cells (29) . Human PAWR is a unique pro-apoptotic protein that selectively induces apoptosis in cancer cells and sensitizes cells to the action of multiple apoptotic stimuli and causes tumor regression (30) . Human PAWR is a 340 amino acid protein alternatively known as prostate apoptotic response-4 (PAR-4). PAR-4 was first identified in prostate cancer cells undergoing apoptosis in response to an exogenous insult (31) . PAR-4 was later rediscovered in human cells as a regulator of the WT1 (32), thus named as PAWR. Interestingly, PAWR is localized to the nucleus of human ocular cells and localizes with PITX2. In the developing mouse eye, we detected expression of PAWR in lens and retina at early embryonic stage (e12.5) and co-localization with PITX2 in the periocular mesenchyme and corneal endothelial cells and stroma at the later stages of development (e14.5 and e18.5) (29) .
Therefore, based on these lines of evidence: (i) PITX2 physically interacts with FOXC1 and inhibits FOXC1 activity (28);
(ii) PAWR physically interacts with PITX2 and inhibits PITX2 activity (29) ; (iii) FOXC1 and FOXC2 have similar structure and overlapping expression pattern; and (iv) FOXC1, FOXC2 and PITX2 all cause human ocular diseases when mutated, we hypothesized that these transcription factors (PITX2, FOXC1 and FOXC2) and a transcription regulator protein (PAWR) are involved in a common regulatory network critical for eye development. In this study, we examined the interactions and functional implications of these proteins at the molecular and cellular levels and investigate if their conserved genetic interactions have a role in ocular development in the zebrafish model organism.
RESULTS

PAWR interacts with both recombinant FOXC2 and FOXC1
Interaction of PAWR and FOXC2 was first observed in yeast cells (Supplementary Material, Fig. S1 ) and further confirmed by Ni 2+ pull-down assays. Full-length PAWR was cloned into a bacterial expression vector (pET28a) that allowed expression of PAWR as a 6XHIS-tagged fusion protein in bacteria (E. coli). Incubation of bacterial extract with Ni 2+ -agarose beads bound 6XHIS-tagged PAWR to the beads. Next, whole cell lysate prepared from HTM cells, transfected with V5 epitope-tagged FOXC2, was incubated with either empty Ni 2+ beads or Ni 2+ beads containing the 6XHIS-tagged PAWR fusion protein. Immunoblot analyses using an anti-V5 antibody detected the presence of FOXC2 with 6XHIS-tagged PAWR Ni 2+ beads (Fig. 1C) . The interaction between PAWR and FOXC1 was also confirmed by Ni 2+ pulldown assays (Fig. 1A) . In the latter experiments, FOXC1 or FOXC2 expressed as 6XHIS-tagged fusion proteins in bacteria (E. coli) was bound to Ni beads, and then incubated with HTM cells transfected with HA epitope-tagged PAWR. Immunoblot analyses using anti-HA antibody detected the presence of PAWR in Ni 2+ beads with 6XHIS-tagged FOXC1 (Fig. 1B ) or FOXC2 (Fig. 1D) .
The interaction of FOXC1 and FOXC2 with endogenous PAWR in HTM cells was also confirmed by the co-immunoprecipitation assay where the cells were first transfected with either V5-tagged FOXC2 or FOXC1 (pcDNA vector) or the empty pcDNA vector as control. Immunoprecipiation using an anti-PAWR antibody (Abcam; ab5787) followed by immunoblotting using the anti-V5 antibody (Invitrogen) resulted in immunoprecipitated V5-FOXC1 (Fig. 1E ) and V5-FOXC2 (Fig. 1F) .
Recombinant FOXC2 interacts with recombinant PITX2
HTM cells were co-transfected either with the combination of empty pcDNA4 vector and V5-tagged FOXC2 in pcDNA3 vector or the combination of Xpress-tagged PITX2 in pcDNA4 and V5-tagged FOXC2 in pcDNA3. Immunoprecipitation using an anti-Xpress antibody (Invitrogen) to XP-PITX2 followed by immunoblotting using the anti-V5 antibody (Invitrogen) resulted in immunoprecipitated FOXC2 (Fig. 1G) -agarose beads. At the same time, cell lysates prepared from HeLa cells transfected with V5-tagged FOXC2 were incubated with 6xHis-FOXC1 bound to Ni 2+ -agarose beads. As a negative control, the same amount of cell lysate was incubated with empty Ni 2+ -agarose beads. Immunoblot analysis using an anti-V5 antibody showed that FOXC1 and FOXC2 could interact with each other in both pull-down assays ( Fig. 1H and I) .
The C-terminal leucine zipper (LZ) domain of PAWR interacts with both FOXC1 and FOXC2. Three N-terminal deletion constructs of PAWR were created based on known PAWR protein domains to identify the region of PAWR that interacts with FOXC1 and FOXC2. The largest PAWR deletion construct (D1 -70) represents the original PAWR protein fragment identified as an interactor with PITX2 and FOXC2 from yeast two-hybrid (Y2H) screening, while the D1-161-PAWR construct lacks the known NLS motif and the smallest D1-267-PAWR construct contains only the known C-terminal LZ domain in PAWR ( Fig. 2A) . These deletion constructs in the pET28 vector were transformed independently in E. coli cells. 6XHIS-tagged fragments were then purified using Ni 2+ -agarose beads (29) . Subsequently, whole cell lysates were prepared from HTM cells transfected with V5-tagged FOXC1 or FOXC2 and subjected to Ni 2+ pull-down assays. Specific FOXC1 bands were detected by immunoblot analyses treated with anti-V5 antibody after incubation with all these three PAWR deletion fragments. Similar results were obtained for V5-FOXC2 as well (upper panel, Fig. 2B ). Duplicate immunoblots of the same experiment, but treated with an anti-His antibody to detect recombinant PAWR, showed the expression of correct-sized fragments of PAWR in E. coli cells (lower panel, Fig. 2B ). This experiment indicated that the shortest PAWR fragment containing only the C-terminal LZ domain is sufficient to interact with both FOXC1 and FOXC2.
FOXC1 and FOXC2 interact with PAWR through their inhibitory domain
Ni 2+ pull-down assays were used to identify the specific region of FOXC1 and FOXC2 that interacts with PAWR. Cell lysates from HTM cells transfected with a HA epitopetagged PAWR construct were incubated with Ni 2+ beads containing 6XHIS-tagged deletion constructs of either FOXC1 or FOXC2 (Fig. 3A) . Subsequent poly-acrylamide gel electrophoresis (PAGE) and immunoblot analysis showed that all constructs including wild-type FOXC1 and FOXC2 bound HA-PAWR in the immunoblot using an anti HA antibody (upper panel, Fig. 3B and C) , except for the FOXC1-FHD and FOXC2-FHD constructs, which only contain the FHD. These data suggested that both FOXC1 and FOXC2 interact with PAWR through their inhibitory domains (IDs). Duplicate Fig. S2 ). The upstream regulatory elements of the FGF19 and FOXO1A genes containing FOXC-binding sites were recovered by PCR amplification from FOXC1, FOXC2 and histone-H3-acetylated lysine-9 immunoprecipitates. Our ChIP analysis data indicate that both FOXC1 and FOXC2 can occupy the regions of FGF19 and FOXO1A genes required for FOXC activation of these genes in vivo (Fig. 4A ). Dual-luciferase assays were performed to test if FOXC2 can activate transcription from the FGF19 or FOXO1A regulatory elements in HeLa cells. The FGF19UPE luciferase construct (33) was co-transfected into HeLa cells with pcDNA4-FOXC1 or pcDNA4-FOXC2 or empty pcDNA4 plasmids into HeLa cells. Luciferase activity was enhanced in the cells when either FOXC1 or FOXC2 was transfected (Fig. 4B) . Similarly, FOXC1 and FOXC2 also enhanced the expression from the FOXO1ARE luciferase construct containing upstream regions of the FOXO1A gene, placed in front of the luciferase gene (34) (Fig. 4C ).
PAWR exerts different regulatory effects on different FOX target sites
The role of PAWR in regulating FOXC1 and FOXC2 transcriptional activity was studied further in HTM cells by dualluciferase assays where a luciferase reporter driven by a thymidine kinase (TK) promoter containing six FOX binding sites (6XBS) upstream was used to measure either FOXC1 or FOXC2 transcriptional activity in the presence of PAWR. HTM cells coexpressing PAWR and either FOXC1 or FOXC2 showed significantly enhanced transcriptional activity when compared with cells expressing FOXC1 or FOXC2 alone (P , 0.01) ( Fig. 5A and B) . We further examined the transcriptional activity of both FOXC1 and FOXC2 in combination with PAWR on FGF19 (FGF19UPE) and FOXO1A (FOXO1ARE) regulatory element luciferase constructs described previously (33, 34) . While FOXO1ARE and FGF19UPE luciferase constructs showed enhanced activity in the presence of either FOXC1 or FOXC2 as demonstrated earlier ( Fig. 4B and C) , co-expression of FOXC1 and PAWR also significantly increased activity from the FGF19UPE luciferase reporter in HTM cells (P , 0.001) ( Fig. 5A and B) . Similar results were obtained when FOXC2 was co-expressed with PAWR on FGF19UPE regulatory element (P , 0.001) ( Fig. 5A and B) . However, co-expression of PAWR with either FOXC1 or FOXC2 displayed different results with the FOXO1A regulatory element luciferase reporters than observed with the FGF19UPE or 6XBS luciferase reporters. FOXC1 in combination with PAWR showed significantly reduced promoter activity on FOXO1ARE in HTM cells (P , 0.001) when compared with FOXC1 alone. Similar results were obtained when FOXC2 was co-expressed with PAWR on FOXO1ARE regulatory element (P , 0.001) ( Fig. 5A and B). For both FOXC1 and FOXC2, immunoblot experiments showed that there was no change in the protein level with addition of PAWR (Supplementary Material, Fig. S4 ). These results indicate that PAWR modulation of FOXC1 or FOXC2 activity is target gene specific.
PAWR and FOXC2 synergistically increase PITX2 activity
Previously we reported that HTM cells co-expressing both PITX2 and PAWR have 50% reduced PITX2 transcriptional activity when compared with cells expressing PITX2 alone (29) . Here we used the same luciferase reporter containing a PITX2-binding site (bicoid) upstream of the TK promoter to measure PITX2 transcriptional activity. In three independent experiments, the luciferase construct (bicoidBS-TK) was co-transfected with V5-tagged LacZ (negative control), Xpress-tagged PITX2 alone, Xpress-tagged PITX2 and PAWR, Xpress-tagged PITX2 with V5-tagged FOXC2 and PITX2, or PAWR with increasing amount of FOXC2 in HTM cells. Luciferase activity from cells expressing LacZ was used to establish the background activity of the bicoid PITX2 reporter (Fig. 5C , column 2, and D, lane 2). As a positive control, PITX2 alone was able to significantly transactivate from the bicoid PITX2 reporter (Fig. 5C, column 3 , and D, lane 3). Addition of PAWR reduced PITX2 activity (P , 0.001) consistent with our previous findings (29) (Fig. 5C , column 4, and D, lane 4). When FOXC2 was added with PITX2, there was no change of PITX2 activity (Fig. 5C , column 5, and D, lane 5). Interestingly, when increasing the amount of FOXC2 was added in combination with a constant amount of PITX2 and PAWR, there was a significant and pitx2 and foxc1 morpholino-injected embryos show phenotypic alterations in zebrafish
We further investigated this regulatory network in the zebrafish in vivo model. Zebrafish are a well-documented and efficient system to study ocular and other developmental processes. We designed splice-site blocking (SB) morpholinos (MOs) targeting zebrafish pitx2 and pawr. Fig. S5B ). For pitx2SBa, amplification products from RT -PCR experiments were sequenced with ZF-PITX2-F1 and ZF-PITX2-R1 primer sets (Supplementary Material, Table S1 ) and identified six in-frame stop codons, predicted to result in a truncated pitx2 protein in zebrafish. pitx2SBa MOs were thus used in subsequent pitx2 MO experiments. Two different doses [low (2.5 ng/embryo) and high (5 ng/embryo)] of pitx2SBa MOs were injected into wild-type zebrafish (AB) embryos at the one-to two-cell stages. MO-injected embryos were examined for phenotypic alterations at 48 h postfertilization (hpf). Both doses of the pitx2SBa MO showed a number of gross phenotypes, including heart edema, slight hydrocephaly, overall reduced length and ventrally curved tail in injected embryos (Fig. 7B) . At a lower frequency, ocular hemorrhage, especially around the iris, was observed with both low (14%) and high (29%) dose of injection (Fig. 7C , Table 1 Table S1 ) identified the exon-intron boundary generated from successful SB by the pawrSBa MO. Further in silico analysis of intron 2 in zebrafish pawr revealed 11 in-frame stop codons within 1065 bp from 5 ′ start site of intron 2. All these 11 stop codons are predicted to lead to a truncated zebrafish pawr protein. These MO-injected embryos did not reveal any obvious phenotype at 48 and 72 hpf. Injection of translation-blocking foxc1 MOs resulted in phenotypes including incidence of hemorrhage with lower (1.63 ng/embryo) dose of injection of foxc1dMO (a combination of foxc1a and foxc1b MOs), while higher (3.25 ng/embryo) dose resulted in hydrocephaly and grossly reduced body length ( Fig. 7E and F) . The observed phenotypes with foxc1dMO are consistent with those reported previously (35) .
Genetic interaction demonstrated by concerted knockdown of pitx2, pawr and foxc1
We observed phenotypes by using different doses of pitx2, and foxc1 MOs individually (above). To study the genetic interaction between pitx2, foxc1 and pawr, we first determined the sub-effective doses for each MO reagent (pitx2SBa: 2 ng/ ChIP input is a 1:10,000 dilution of cross-linked chromatin used for immunoprecipitations. Immunoprecipitated DNA was PCR amplified using primers designed to amplify regions flanking putative FOXC binding sites on the regulatory elements of the FGF19 and FOXO1A genes. (B and C) Transactivation assays. The FGF19UPE luciferase construct (B) and the FOXO1ARE luciferase construct (C) were co-transfected with empty pcDNA4 or pcDNA4-FOXC1 expression vector or pcDNA4-FOXC2 expression vector into HeLa cells. In all cases, pRLCMV renilla luciferase expressing plasmid has been taken as transfection control. Activity of firefly luciferase was normalized by that of renilla luciferase and the value of the empty pcDNA4 vector was scaled to 1. embryo; pawrSBa: 5 ng/embryo; foxc1dMO: 1.2 ng/embryo), defined as a dose of MO that does not produce any phenotype. Appearance of phenotypes using combinations of MOs at subeffective doses confirms a genetic interaction between two gene products. We excluded that phenotypic effects are due to the amount of MO injected, because none of the sub-effective dose MOs showed any phenotype when they were coinjected with a control MO (Supplementary Material, Fig. S7 ). Combinations of sub-effective doses of the MOs described above were coinjected into wild-type zebrafish (AB) embryos as well as into Tg(gata1:dsRed)sd2/+ (obtained from Zebrafish International Resource Center) embryos, expressing dsRed in blood cells (36) . Sub-effective doses of pitx2SBa with pawrSBa resulted in hemorrhage around the iris in the eye (Fig. 8AII and V, Table 1 ) at 48 hpf, seen in bright-field, O-Dianisidine staining (37) (Fig. 8A ) and live transgenic embryos (Fig. 8C ). The same phenotype had been observed with the effective dose of pitx2SBa alone (Fig. 7D, Table 1 ). We also observed hemorrhage in the central nervous system (CNS) for the combination of pitx2SBa and pawrSBa subeffective doses (Fig. 8AV and VIII) . Coinjection of foxc1dMO and pawrSBa sub-effective doses resulted in hydrocephaly in 87.4% cases of injected embryos (Fig. 8BIII, Table 1 ) and hemorrhage in the CNS for 23.6% of injected embryos (Fig. 8BII, Table 1 ). The hemorrhage in the CNS phenotype was also observed in Tg(gata1:dsRed)sd2/+ live transgenic embryos injected with foxc1dMO and pawrSBa sub-effective doses (Fig. 8C) . Coinjection of the sub-effective doses for FOXC2 (B) . Each set of experiments was performed by transfecting pcDNA4 vector (EV), pcDNA4 XP-FOXC1/pcDNA4 XP-FOXC2 expression vector, pcDNA4 XP-PAWR expression vector and co-transfecting either pcDNA4 XP-FOXC1+pcDNA4 XP-PAWR or pcDNA4 XP-FOXC2+pcDNA4 XP-PAWR expression vectors. Empty pcDNA4 vector was added accordingly in each experiment to equalize the total amount of plasmids transfected. In all cases, pRLCMV renilla luciferase expressing plasmid has been taken as transfection control. Luciferase activity was measured followed by normalizing it with renilla luciferase activity and bars were made according to relative luciferase activity along y-axis considering pcDNA4 vector alone (EV) as 1. (C) PAWR and FOXC2 cause synergistic effect of increased PITX2 activity in HTM cells. HTM cells were transfected with TK-bicoidBS luciferase construct along with PITX2 expression vector alone, PITX2 and PAWR together, PITX2 and FOXC2 together and PITX2, PAWR with increasing amount of FOXC2. Empty pcDNA4 vector was added accordingly in each experiment to equalize the total amount of plasmids transfected. LacZ expression vector was used as negative control. In all cases, pCMV-b gal expressing plasmid has been taken as transfection control. Luciferase activity was measured followed by normalizing it with b gal activity and bars were made according to relative luciferase activity along y-axis considering empty vector (EV) as 1. (A-C) Statistical significance measured by Student's t-test.
* P , 0.5, * * P , 0.01 and * * * P , 0.001. (D) Immunoblot experiment corresponding to (C) shows expression of LacZ, PITX2, PAWR and FOXC2 proteins. Addition of FOXC2 in increasing amount (lanes 6 -8) proportionately increases PITX2 transactivation, while expression of PITX2 and PAWR remains constant. Superoxide dismutase protein is used as loading control in the immunoblot experiment. (Fig. 8DIII , Table 1 ). Phenotypes were unchanged when an MO targeting p53 was coinjected (data not shown), suggesting that the MOs do not promote phenotypes through off-target-mediated cell death (38) . Overall, these gene knockdown data confirm the in vivo pair-wise genetic relationships between pitx2, pawr, and foxc1 in zebrafish. Further, the data implicate a role for these pathways in development or maintenance of ocular vasculature.
DISCUSSION
The anterior chamber and iridocorneal angle in the eye are associated with the physiology of aqueous humor outflow from the eye, disruption of which is a significant risk factor for glaucoma. The homeobox (PITX2) and forkhead box (FOXC1 and FOXC2) transcription factors are known to be involved in the development of anterior segment, and, when mutated, in disease processes that lead to glaucoma (6, 14, 39, 40) . Moreover, the fact that PITX2 and the transcription regulator protein PAWR co-localize at the emerging iridocorneal angle of a developing mouse eye is consistent with a possible role of PAWR in ocular development (29) .
In the current study, we combine biochemical analyses of human ocular cells with in vivo genetic analysis of a basal vertebrate to reveal a complex-conserved regulatory network involving PITX2, FOXC1, FOXC2 and PAWR. Although PAWR has previously been associated with multiple apoptotic regulatory networks (30) (31) (32) , this is the first demonstration of a role of PAWR in the development regulatory network involved in eye formation and disease. Our studies indicate that PAWR, PITX2, FOXC1 and FOXC2 physically interact in a common regulatory pathway (Fig. 1) . Our co-immunoprecipitation experiments indicated for the first time that both recombinant PITX2 and recombinant FOXC2 interact with each other (Fig. 1G) . Ni 2+ pulldown assays revealed that FOXC1 and FOXC2 physically interact with each other in vitro (Fig. 1H -I) , which, to our knowledge, is the first report of the two FOXC transcription factors being shown to interact with one another. Previously, only members of the FOXP subfamily were known to form homo-or heterodimers through their N-terminal LZ domains (41) . Interestingly, the same C-terminal LZ domain in PAWR that interacts with PITX2 (Acharya JBC 2009) is sufficient to interact with both FOXC1 and FOXC2 (Fig. 2B) . In humans, the LZ domain in PAWR contains 41 amino acids, situated at C-terminal end starting from 300th to the last (340) amino acid residue ( Fig. 2A) and interacts with numerous proteins, including WT1 (32), atypical protein kinase C (42) and DAP like kinase (43) . In parallel, we found that the ID both in FOXC1 and FOXC2 interacts with PAWR ( Fig. 3B and C) . The central transcription ID in FOXC1 spans amino acid residues from 215 to 366. The ID does not have an intrinsic transcriptional repressor activity, but rather inhibits the ability of cis-activation domains to stimulate transcription. These data demonstrate that all possible binary interactions between PITX2, FOXC1, FOXC2 and PAWR occur, and define the domains required for these interactions (Fig. 6A ). Since our data indicated that the highly related FOXC1 and FOXC2 transcription factors are involved in the same pathway, we also determined whether they could regulate the same genes. As the DNA-binding domains of FOXC1 and FOXC2 are 98% identical, we hypothesized that their DNA-binding specificities would also be identical. ChIP and luciferase analyses with previously identified FOXC1 target genes were used to test this hypothesis. The FGF19 and FOXO1A genes had been previously identified as direct targets of FOXC1 in ocular cell lines and the developing zebrafish eye (33, 34) . Fgf19 regulates the development of the cornea through the FGFR4/MAPK (Mitogen-activated protein kinase) pathway. Knocking down of Fgf19 in the developing zebrafish embryo leads to anterior segment dysgenesis in the eye (33) . FOXO1A is a mediator of FOXC1-dependent cell viability and resistance to oxidative stress in the eye (34) . In this study, we found that both FOXC1 and FOXC2, in vivo, bind to the upstream regulatory regions of FGF19 and FOXO1A genes in ocular cell lines (Fig. 4A) . Moreover, both FOXC proteins are able to activate luciferase expression from FGF19 and FOXO1A regulatory elements (Fig. 4B) . These results are consistent with our hypothesis that FOXC1 and FOXC2 share common target genes in ocular tissues. They are also in agreement with several recent studies, which have shown that FOXC1 and FOXC2 can both directly regulate the expression of a number of common down-stream target genes in other, non-ocular tissues (44) (45) (46) . Taken together, our results strongly suggest that the direct downstream target genes of FOXC1 and FOXC2 largely overlap.
The interaction of these proteins profoundly alters the regulation of target gene expression. PAWR does not directly bind to DNA, rather PAWR interacts with different transcription factors exerting different regulatory effects. PAWR has different effects on FOXC protein abilities to regulate the expression from different FOXC target genes. Co-transfection of PAWR with either FOXC1 or FOXC2 reduced transactivation from a FOXO1A promoter for both FOXC1 and FOXC2 in HTM cells (Fig. 5A and B) . This role of PAWR as a transcriptional repressor is consistent with previous findings of PAWR inhibition of WT1 transcriptional activity, downregulating expression of pro-survival proteins like Bcl-2 (47), and PAWR-mediated inhibition of PITX2 transactivation in HTM cells (29) . However, PAWR-mediated enhancement of FOXC transactivation from either the 6X FOX binding site or FGF19 regulatory elements (Fig. 5A and B) suggests, for the first time, that PAWR alters transcription factor activity in a target gene specific fashion. These regulatory effects of PAWR were identical for both FOXC1 and FOXC2 ( 
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Human Molecular Genetics, 2011, Vol. 20, No. 8 and B). The regulatory effects of PAWR on PITX2 were even more complex. When co-expressed with FOXC2 and PITX2, PAWR increased PITX2 transactivation from a bicoid PITX2 reporter (Fig. 5C ), while without FOXC2, PAWR inhibited PITX2 transactivation from the same reporter (Fig. 5C ) (29) . Co-expression of either FOXC1 (or FOXC2) with PITX2, but without PAWR, had no effect on PITX2 activity (Fig. 5C, column 5 , and D, lane 5), consistent with our previous finding where FOXC1 showed no effect on PITX2 transactivation (28) . Interestingly, addition of increasing amounts of FOXC2 proportionally increased PITX2 activity when both PITX2 and PAWR were present (Fig. 5C , columns 6 -8, and D, lanes 6 -8) . This increase in PITX2 activity in the presence of FOXC proteins and PAWR was significantly greater than the activity of PITX2 alone (P , 0.001). FOXC2 only exerted this effect on PITX2 activity when co-expressed with PAWR (Fig. 5D) .
We interpret this to mean that the addition of FOXC2 did not simply displace PAWR from PITX2 -PAWR complexes to 'free' PITX2 from the repressing effect of PAWR. Rather FOXC2, PAWR and PITX2 act together to increase PITX2 transactivation activity. While the same region of PAWR (the LZ domain) interacts with PITX2, FOXC1 and FOXC2 (Fig. 6A) , these results eliminate the possibility of simple competition of binding PITX2, FOXC1 and FOXC2 with PAWR. These results reveal the complex nature of the regulatory network involving these proteins (Fig. 6B-D) and also indicate an important role of PAWR in regulating PITX2 and FOXC transactivation abilities. Also, it is evident that the differences in luciferase activity in all these experiments are not due to changes in steady-state levels of the transfected proteins (Fig. 5D, Supplementary Material, Fig. S4 ). Since we have shown that all four proteins (PITX2, PAWR, FOXC1 and FOXC2) in this regulatory network are capable of directly interacting with each other (Fig. 6A) , stabilization or destabilization of protein complexes formed by PITX2, PAWR, FOXC1 and FOXC2 might be a mechanism that can regulate the rate of transcription at the cellular level.
To investigate further the biological consequence of this complex regulatory network, we studied the genetic interaction between these transcription factors and regulators in the zebrafish model by MO knockdown experiments. Although four proteins were involved in this regulatory network (PITX2, PAWR, FOXC1 and FOXC2), our study was restricted to pitx2, pawr and foxc1, since foxc2 is not found in zebrafish. We assume that the two zebrafish orthologues foxc1a and foxc1b (which we always knockdown together) have similar functions as the combined action of human FOXC1 and FOXC2. For our MO knockdown studies, we designed SB MOs for zebrafish pitx2 and pawr. We report for the first time that knocking down zebrafish pitx2 results in heart edema, hydrocephaly and vascular defects in the eye (Fig. 7B) . Zebrafish pitx2 is expressed in the lateral plate mesoderm and diencephalon during early embryonic development, thus disrupting the translation of this protein is predicted to produce developmental defects, including AP truncation and hydrocephalus. Our observation of hydrocephaly, reduced body length and cardiac edema in pitx2 morphants (Fig. 7, Table 1 ) is consistent with this prediction (48) (49) (50) (51) . Hemorrhaging around the iris found in pitx2 MO-injected embryos is similar to the vascular defects observed in the foxc1dMO-injected embryos described previously (35) . This suggests that the role of pitx2 in zebrafish development could be similar as foxc1. The resultant zebrafish phenotypes do not exactly correspond with the human ocular diseases resulting from mutations of FOXC1 or PITX2. However, as the same ocular developmental tissues are involved in both species, we are confident that we can use zebrafish as a model to explore the function of these transcription factors in ocular development.
Consistent with PAWR-modulated regulation of FOXC1 and PITX2 activities in ocular cells, knockdown of zebrafish pawr using sub-effective dose (pawrSBa) sensitized fish to hemorrhage around the iris and in the CNS during coinjection of pitx2SBa (Fig. 8A and C, Table 1 ) and foxc1dMO (Fig. 8B and C, Table 1 . In the mouse, we previously detected pawr protein in the mesenchyme of the presumptive iridocorneal angle at different developmental stages (29) . Our genetic interaction experiments demonstrate involvement of pawr in the same developmental pathway with foxc1 and pitx2, likely affecting basement membrane formation and vasculogenesis. Our observation is consistent with previous foxc1 knockdowns showing the role of foxc1 in vasculogenesis and basement membrane defects with increased permeability and hemorrhaging in CNS vessels (33-35,52 ). Interestingly, an additive effect of pitx2SBa and foxc1dMO MOs produced grossly reduced brain size, necrosis and hydrocephaly that was not observed when these MOs were applied individually (Fig. 8D, Table 1 ), strongly supporting that foxc1 and pitx2 are critically involved in brain morphogenesis. Phenotypes arising from pitx2SBa and foxc1dMO co-injections mirror phenotypes observed in single MO injections almost entirely (reduced body size, curved tails, heart edema, hydrocephaly and necrosis were all seen in pitx2SBa high-dose injections and partly in foxc1dMO high-dose injections; Table 1 ). Since injection of the foxc1dMO leads to both hydrocephaly as well as hemorrhage in the CNS, it is not unexpected to see a brain phenotype in the double injections. The fact that the brain phenotype seems more severe in the co-injections may be attributable to knocking down two genes of the pathway that aggravates the phenotype/effect on the embryo. Therefore, our MO knockdown analysis in zebrafish demonstrates a genetic interaction between foxc1, pitx2 and pawr, where pawr exerts subtle regulatory effects on both foxc1 and pitx2 function.
Taken together, our data reveal a complex regulatory network of transcription factors (PITX2, FOXC1 and FOXC2) and regulators (PAWR). The genetic interaction analyses in zebrafish indicate that these interactions are conserved and have biological significance. All three transcription factors are critical for ocular development and are directly associated with anterior segment defects and glaucoma when mutated. PAWR is critically involved in this regulatory network, altering the regulation of target gene expression through these transcription factors, in a target-specific manner. Our results tie these four proteins into a common regulatory pathway Human Molecular Genetics, 2011, Vol. 20, No. 8 1619 fundamentally important for correct eye development and function. We have therefore identified a functional link between three transcription factors, modulated by PAWR, which we propose underlies the similar ocular phenotypes and glaucoma pathology caused by mutations of these genes.
MATERIALS AND METHODS
Plasmid constructs
Most of the plasmid constructs and reagents used in this study were already described in our previous publications. The open-reading frame of human PAWR was amplified by PCR and subcloned into pcDNA4c/His Max mammalian vector and pET28a bacterial expression vector in-frame to the 6XHIS tag described previously (29) . In this study, human PAWR was further subcloned into a HA-tagged pCI mammalian expression vector. Generation of three PAWR deletion clones was also described in our previous publication (29) . FOXC2 cDNA was amplified by PCR from pcDNA4-FOXC2 (25) and subcloned into pDEST32 (Invitrogen) in-frame to the GAL4DBD or into the pcDNA3.1/nV5-DEST vector (Invitrogen) in-frame to the V5 epitope by gateway technology. This FOXC2-pDEST32 construct was used in the Y2H analysis. N-terminally tagged 6xHis-FOXC1 bacterial expression vector, pET28-FOXC1 has been described previously (21) , while 6xHis-FOXC2 in pET28b was made in this study. Also, FOXC1 full-length cDNA was amplified by PCR from pcDNA4-FOXC1 (22) and subcloned into the pcDNA3.1/ nV5-DEST vector (Invitrogen) in-frame to the V5 epitope by gateway technology. All FOXC1 and FOXC2 deletion constructs in bacterial expression vector (pDEST17) was made from their entry clone in pDONR221 by LR Recombination reaction (Invitrogen). The pGL3-TKluciferase reporter vector under the control of a 1.3 kb amplicon of the FGF19 upstream region (FGF19UPE), which contains a FOXC binding site, Table 1 ) and high (29.3%, Table 1 ) dose of injections. All zebrafish embryos were PTU treated (blocker of pigment production) and photographs were taken at 48 hpf in these experiments.
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was constructed in our laboratory and has been described previously (33) . The pGL3-basic luciferase reporter vector under the control of a DNA fragment, corresponding to 580 bp upstream and 250 bp downstream of the putative transcription start site of the FOXO1A gene (FOXO1ARE), was also built in our lab and has been described previously (34) . All newly built vectors were sequenced to confirm that no mutations were introduced into the cDNAs and the cDNAs were in-frame to the epitopes.
Y2H screening
An HTM cDNA library fused to the GAL4AD of pEXP-AD502 (Invitrogen) was screened for proteins that interact with human FOXC2, using the ProQuest Two-Hybrid System (Invitrogen). The detailed method of Y2H screening was already described previously (53) .
Mammalian cell culture and transfection
HeLa cells, COS-7 cells and HTM cells were maintained in Dulbeco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum in a 378C, humidified incubator under an atmosphere containing a constant 5% CO 2 .
The day prior to transfections, plates were seeded (10 6 cells in 10 ml media per 100 mm Petri dish, 4 × 10 5 cells in 4 ml media for 60 mm Petri dish, 2 × 10 5 cells in 2 ml media per 25 mm well or 4 × 10 4 cells in 1 ml media per well of 24 well plate) so as to reach 30-50% confluence the following day. Transfections were performed using FuGene 6 (Roche) or Table 1 ) and (III) hydrocephaly with the overall reduced length (87.4%, Table 1 ) in MO-injected embryos. (C) Co-injection of pitx2SBa + pawrSBa and foxc1dMO + pawrSBa sub-effective doses into Tg(gata1:dsRed)sd2/ + transgenic zebrafish, demonstrating hemorrhage around the iris (arrows) and CNS in live embryos. (D) Coinjection of pitx2SBa (2 ng/embryo) and foxc1dMO (1.2 ng/embryo) sub-effective doses. I. Control showing no phenotype. II Majority of the MO-injected embryos showed significantly reduced brain size in combination with heart edema and overall reduced body length (53.5%, Table 1 ). III. In some embryos hydrocephaly, ocular cell death and overall reduced body length was found (35.7%, Table 1 ). All zebrafish embryos are PTU (blocker of pigment production)-treated (except for C) and photographs were taken at 48 hpf.
Trans IT-LT1 (Mirrus Bio) according to the manufacturer's protocol, while 4, 1.6 or 0.8 mg of total DNA was used for transfections in 100 mm, 60 mm or six-well dishes, respectively. Transfected cells were subjected to single-or dualluciferase assays (Promega) after 48 h.
Nickel pull-down assay
For PAWR deletion constructs, 6XHIS-tagged PAWR and/or its deletion fragments were generated in E. coli using pET28-based constructs containing inducible lac operator sequence. These constructs were transformed into Rosetta 2 (Novagen) strain of E. coli to maximize the bacterial expression. One micromolar of isopropyl b-D-1-thiogalactopyranoside was used to induce production of desired proteins in bacterial cells. FOR FOXC1 and FOXC2 deletion constructs, 6XHIS-tagged FOXC1 and FOXC2 with their deletion fragments were generated in E. coli using pDEST17-based constructs containing inducible arabinose operator sequence. Later, they were transformed into BL21-AI strain (Invitrogen) of E. coli to maximize the bacterial expression and 0.2% of L-arabinose was used to induce production of desired proteins in bacterial cells. All these proteins were purified using Ni 2+ -agarose beads (Qiagen). Whole HTM or HeLa cell lysates containing different FOXC1 and PAWR constructs were prepared using lysis buffer described previously (53) and measured thereafter by the Bradford assay. The Ni 2+ -agarose assay was done according to the protocol described earlier (53) . Protein complexes captured on the beads were eluted in sodium-dodecyl sulphate-poly-acrylamide gel eletrophoresis (SDS -PAGE) loading buffer, separated by 12% SDS -PAGE and subjected to immunoblot analysis with antibody against both mammalian and bacterially expressed proteins.
Immunoprecipitation
Protein-G agarose beads (Sigma) were subjected to three times 1X PBS wash followed by 1 h incubation in 1% BSA in PBS at 48C. After incubation, the beads were centrifuged at 1000g and kept at 48C with equal amount of radioimmunoprecipitation assay buffer as described earlier (28) . For immunoprecipitation of FOXC1 and FOXC2, HTM cells were transfected with FOXC1 and FOXC2 expressing mammalian expression vector (pcDNA3.1-V5-FOXC1 and pcDNA3.1-V5-FOXC2) or the empty vector (pcDNA3.1). The cells were lysed after 48 h of transfection in the lysis buffer as described previously (53) . The immunoprecipitation experiments were done as described previously (29) using antibody against human PAWR (Abcam). Protein complexes captured on the beads were eluted in SDS -PAGE loading buffer, separated by 12% SDS -PAGE and subjected to immunoblot analysis with antibody against V5 tag (Invitrogen). For FOXC2 and PITX2 co-immunoprecipitation experiments, HTM cells were co-transfected either with pcDNA4 empty vector or pcDNA4-XP-PITX2 and pcDNA3.1-V5-FOXC2. The cells were lysed using same buffer described earlier and subjected to immunoprecipitation assays using antibody against Xpress tag (Invitrogen). Subsequent immunoblot analysis was done using antibody against V5 tag (Invitrogen). Input fraction represented 5% of the protein extract used for all immunoprecipitation experiments.
Chromatin immunoprecipitation (ChIP)
Approximately 10 8 NPCE cells were used for ChIP analyses. The detailed method of ChIP experiment was already described previously (33) . A 100 bp fragment in the FGF19 regulatory element containing a FOXC-binding site was amplified with the following primer set: 5 ′ -GCAGCCAAGC CAGTTAGC-3 ′ and 5 ′ -AGATCCTCCAGCCGGAAC-3 ′ . A 140 bp fragment in the FOXO1A regulatory element containing a FOXC-binding site was amplified with the following primer set: 5 ′ -AGTACTCGGCTCTGCTGCTC-3 ′ and 5 ′ -GGGGTAGTGGGGTGTTTTTC-3 ′ .
Reporter transactivation assay
For FOXC1 and FOXC2, transactivation assays were performed using the Promega Dual-luciferase reporter assay system according to the manufacturer's instructions. HeLa, HTM and Cos-7 cells on 24-well tissue culture plates (4 × 10 4 per 15 mm well, 24-well plate) were transfected, respectively, with FOXC1, FOXC2 and PAWR mammalian expression vectors, FOXC1 + PAWR and FOXC2 + PAWR expression vectors, along with either pGL3-TK-6XBS or pGL3-TK-FGF19UPE or pGL3-basic-FOXO1ARE luciferase reporter, and pRL-CMV (Promega). The total amount of transfected DNA was equalized with empty vectors. The transactivation assays were performed 48 h after transfection. Cells were harvested and assayed for sequential firefly and renilla luciferase activity according to the manufacturer's protocol (Promega). For PITX2 transctivation assays, HTM cells were cultured on a 24-well tissue culture plates followed by transfection of PITX2, PITX2 + PAWR, PITX2 + FOXC2 and PITX2 + PAWR with increasing amount of FOXC2 mammalian expression plasmids along with 60 ng of the pGL3-bicoidBS-TK reporter (21) and 60 ng of the pCMVb transfection control vector. The total amount of transfected DNA was equalized with empty vectors. Mammalian expression vector expressing LacZ was taken as negative control. After 48 h of transfection, cells were harvested and assayed for luciferase activity as described previously (29) .
Fish care and strains
Zebrafish of the AB strain were used as the wild-type strain, and the transgenic line Tg(gata1:dsRed)sd2/+(purchased from ZIRC and originating from the Zon Lab) (36) was used for visualizing hemorrhage phenotypes. Zebrafish were maintained at 288C under a 14/10 h light/dark cycle and bred and crossed as described previously (54) . Larvae were raised in embryo medium [containing (in mM) 5 NaCl, 0.17 KCl, 0.33 CaCl 2 and 0.33 MgSO 4 ] with 1-phenyl 2-thiourea (PTU) to suppress pigmentation until 72 hpf. All procedures involving zebrafish were approved under the auspices of the University of Alberta Animal Care and Use Committee for Biosciences.
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MO knockdown and RT -PCR analysis
SB antisense MOs targeting pitx2 and pawr were designed and ordered from Gene Tools. MO sequences are described in Supplementary Material, Table S1 . Sequences of foxc1 MOs were described previously (35) . MO stocks were diluted 10 mM KCl and 25% Phenol Red, and respective doses injected into 1 -2 cell-stage embryos using calibrated injection volumes. MO-injected embryos were collected in RNALater (Ambion) and subjected to RNA isolation using RNeasy Mini kit from Qiagen according to the manufacturer's protocol. Reverse transcription reaction was done after DNAse digestion of RNA according to the manufacturer's protocol (Invitrogen) to get rid of possible genomic DNA contamination. cDNA made from RNA samples was subjected to a PCR reaction using appropriate primers (Supplementary Material, Table S1 ).
O-Dianisidine staining of MO-injected embryos
Embryos were dechorionated at 48 hpf and incubated for 15 min in the staining solution containing 2.45 mM O-dianisidine in 40% ethanol with 10 mM sodium acetate and 0.65% hydrogen peroxide at room temperature. Embryos were rinsed afterwards four times, each with 5 min duration followed by immediate image capture using a camera (Olympus DP72) attached to a stereomicroscope (Leica MZ16F).
